Molecular screening of patients with profound hearing loss from Chengdu, China.

MLA

Dai, Qingqing, et al. “Molecular Screening of Patients with Profound Hearing Loss from Chengdu, China.” Acta Oto-Laryngologica, vol. 142, no. 1, Jan. 2022, pp. 57–60. EBSCOhost, https://doi.org/10.1080/00016489.2021.2014564.

APA

Dai, Q., Dai, W., Wang, D., Liu, X., Zou, L., Chen, J., Zheng, H., & Duan, M. (2022). Molecular screening of patients with profound hearing loss from Chengdu, China. Acta Oto-Laryngologica, 142(1), 57–60. https://doi.org/10.1080/00016489.2021.2014564

Chicago

Dai, Qingqing, Wei Dai, Dan Wang, Xia Liu, Ling Zou, Jiani Chen, Hong Zheng, and Maoli Duan. 2022. “Molecular Screening of Patients with Profound Hearing Loss from Chengdu, China.” Acta Oto-Laryngologica 142 (1): 57–60. doi:10.1080/00016489.2021.2014564.